Profund Advisors LLC Horizon Therapeutics Public LTD CO Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $217,459 - $254,280	-2,197 Reduced 14.78%	12,664 $1.47 Million
Q2 2023 Aug 10, 2023	BUY	$96.34 - $112.38 $349,232 - $407,377	3,625 Added 32.26%	14,861 $1.53 Million
Q1 2023 May 11, 2023	SELL	$107.32 - $113.5 $1.51 Million - $1.59 Million	-14,041 Reduced 55.55%	11,236 $1.23 Million
Q4 2022 Feb 02, 2023	BUY	$62.39 - $113.8 $9,732 - $17,752	156 Added 0.62%	25,277 $2.88 Million
Q3 2022 Nov 04, 2022	SELL	$58.92 - $84.67 $67,522 - $97,031	-1,146 Reduced 4.36%	25,121 $1.56 Million
Q2 2022 Aug 01, 2022	SELL	$79.4 - $116.36 $158,006 - $231,556	-1,990 Reduced 7.04%	26,267 $2.1 Million
Q1 2022 May 10, 2022	SELL	$86.42 - $109.81 $253,469 - $322,072	-2,933 Reduced 9.4%	28,257 $2.97 Million
Q4 2021 Feb 08, 2022	SELL	$98.56 - $119.91 $536,166 - $652,310	-5,440 Reduced 14.85%	31,190 $3.36 Million
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $159,096 - $191,050	-1,731 Reduced 4.51%	36,630 $4.01 Million
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $2.3 Million - $2.56 Million	26,715 Added 229.39%	38,361 $3.59 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $242,929 - $322,913	-3,382 Reduced 22.5%	11,646 $1.07 Million
Q4 2020 Feb 09, 2021	BUY	$67.0 - $84.39 $117,116 - $147,513	1,748 Added 13.16%	15,028 $1.1 Million
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $243,453 - $352,331	-4,408 Reduced 24.92%	13,280 $1.03 Million
Q2 2020 Aug 03, 2020	BUY	$30.2 - $56.98 $66,983 - $126,381	2,218 Added 14.34%	17,688 $983,000
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $3,581 - $5,552	-144 Reduced 0.92%	15,470 $458,000
Q4 2019 Feb 18, 2020	BUY	$25.43 - $36.67 $47,859 - $69,012	1,882 Added 13.71%	15,614 $565,000
Q3 2019 Nov 12, 2019	SELL	$23.0 - $27.97 $68,310 - $83,070	-2,970 Reduced 17.78%	13,732 $374,000
Q2 2019 Aug 13, 2019	BUY	$22.81 - $28.48 $380,972 - $475,672	16,702 New	16,702 $402,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account